20:32 IST
BSE
Other Announcement
Natco Pharma Other Announcement
Natco Pharma Limited has filed its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26.
Natco Pharma Ltd
- Share price
- ₹810.70
- Market cap
- ₹15,903 Cr
- Revenue (annual)
- ₹4,078 Cr
- Net profit (annual)
- ₹1,418 Cr
- P/E (TTM)
- 13.9×Sector 47.4×
- Promoter holding
- 49.42%+0.00% QoQ
- FII holding
- 16.99%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Earnings Call 6Board Meeting Date 4Financial Results 3Capital Structure Change 3Board Meeting Outcome 3Regulatory Approval 2Other Announcement 2Legal & Regulatory 2Fund Raise 2Acquisition 2Promoter Selling (Off-Market) 1Merger & Restructuring 1Management Change 1Dividend 1Business Update 1Annual Report 1Annual General Meeting 1
Time
2 announcements with these filters
11:41 IST
BSE
Other Announcement
Natco Pharma Other Announcement
Natco Pharma Limited submitted its compliance certificate under Regulation 74(5) of SEBI (DP) Regulations for the quarter ended March 31, 2026. The registrar confirmed that securities received for dematerialization were processed and the depositories' records updated within 15 days.